期刊文献+

小鼠侵袭性肺曲霉菌病模型的建立 被引量:6

Construction of mouse model of invasive pulmonary aspergillosis
原文传递
导出
摘要 目的建立小鼠侵袭性肺曲霉菌病(IPA)的动物模型。方法将90只小鼠随机分为5组,模型组:于接种前4天和接种前1天腹腔注射环磷酰胺200 mg/kg,通过鼻腔吸入浓度为1×1011/L烟曲霉菌孢子悬液40μl。非环磷酰胺对照组:除以0.9%氯化钠注射液(NS)代替环磷酰胺外,其余操作同模型组。环磷酰胺对照组:以NS代替烟曲霉菌滴鼻,其余操作同模型组。空白对照组:用NS代替环磷酰胺行腹腔注射,以NS代替烟曲霉菌孢子,其余操作同模型组。重组人粒细胞集落刺激因子(G-CSF)组:在模型组基础上,接种真菌孢子1天后皮下注射G-CSF 20μg kg-1 d-1。通过肺组织病理、肺组织真菌培养和血清半乳甘露聚糖测定(GM试验)等确定肺侵袭性曲霉菌病模型是否构建成功。结果肺曲霉菌培养、血清GM试验和病理切片等结果均表明,模型组和G-CSF组均发生了IPA,其余各组均无IPA发生。结论成功建立了小鼠肺曲霉菌模型。 Objictive To establish a model of invasive pulmonary aspergillosis (IPA) in mouse. Mehtods Total of 90 mouse were divided into 5 groups randomly. Mouse in model group received cyclophosphamide (intraperitoneal 200 mg/kg, 4 th day and 1 st day before inoculation) and aspergillus A. fumigatus conidia suspension (intranasa140 μl/mice, 1 × 10^11/L). Mouse in non-immtmosuppressant control group received normal saline instead of cyclophosphamide and other procedures were the same as the model group. Mouse in immunosuppressant control group received normal saline instead of A. fumigatus conidia suspension and other procedures were the same as the model group. Mouse in normal saline control group received normal saline instead of cyclophosphamide and normal saline instead ofA.fumigatus conidia suspension. Mouse in G-CSF group were given at dose of 20 μg.kg-1.d-1 from 1st day and other procedures were the same as the model group. Pathologic examination, culture of the lungs of mice and GM-test were conducted to determine whether the IPA model was successfully establish. Results IPA was confirmed in all mice in the model group and the G-CSF group 5 days after inoculation ofA. fumigatus conidia based on pathologic examination and culture of lung tissue and GM-test. No-IPA was found in the non-immunosuppressant control group, the immunosuppressant control group and the normal saline control group. Conclusions The IPA model in mouse was successfully constructrued.
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2013年第3期9-12,共4页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
基金 海军总医院创新培育基金(No.CX200907)
关键词 侵袭性肺曲霉菌病 动物模型 Invasive pulmonary aspergillosis Animal model
  • 相关文献

参考文献12

  • 1Denning DW. Therapeutic outcome of invasive aspergillosis. Clin Infect Dis,1996,23(3):608-615.
  • 2Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood,2005, I 06(8):2641-2645.
  • 3Pagano L, Cain M, Cndoni A, et al. The epidemiology of fungal ingections in patients with hematologic malignancies: the + SEIFEM- 2004 study. Haematologica,2006,91(8): I 068-1 075.
  • 4Kauffman HF, Tomee JF. Defense mechanism of the airways against aspergilus fumigatus: role in invasive aspergillosis. Chen Immunlo,2002,81(1):94-113.
  • 5Brakhage AA. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. Curr Drug Targets,2005,6(8):875-886.
  • 6Tansho S, Abe S, Ishibashi H, et al. Efficacy of intravenous itaconazole against invasive pulmonary aspergillosis in neutropenic mice. J Infect Chemother,2006, 12(6):355-362.
  • 7Lewis RE, Liao GL, Hou JG, et al. Comparative analysis of amphotercin B lipid cornlex and fimgal clearance in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother,2007,51( 4): 1253-1258.
  • 8Takemoto K, Yamamoto Y, Ueda Y, et al. Comparative study on the efficacy of AmBisome and Fungizone in mouse model of pulmonary aspergillosisi. J Antimicrob Chemother,2006,57(4):724-731.
  • 9Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomanan screening for early diagnosis of invasive aspergilosis in allogeneic stem cell transplant recipients. J Infect Dis,2002 186(9): 1279-1306.
  • 10姚佳峰,苏东,黄勇,张平,林青松,王志永,冯四洲,韩明哲.半乳甘露聚糖试验诊断血液病患者并发侵袭性曲霉感染的初步探讨[J].中国实验血液学杂志,2009,17(3):765-769. 被引量:7

二级参考文献25

共引文献14

同被引文献40

  • 1肖秀美,肖永红.粒细胞减少小鼠大腿金黄色葡萄球菌感染动物模型的建立[J].中国临床药理学杂志,2007,23(1):45-49. 被引量:11
  • 2邵长周,瞿介明,何礼贤,张艳红,王晋慧.侵袭性肺曲霉菌病鼠模型的建立及γ-干扰素和肺组织细菌负荷的动态变化[J].中国实用内科杂志,2007,27(21):1725-1728. 被引量:2
  • 3Lass-Flrl C,Roilides E,Lffler J,et al.Minireview:host defence in invasive aspergillosis[J].Mycoses,2013,56(4):403-413.
  • 4Hartigan AJ,Westwick J,Jarai G,et al.CCR7 Deficiency on Dendritic Cells Enhances Fungal Clearance in Murine Model of Pulmonary Invasive Aspergillosis[J].J Immunol,2009,183(8):5171-5179.
  • 5Kwon OK,Lee MG,Kim HS,et al.Invasive pulmonary aspergillosis after influenza a infection in an immunocompetent patient[J].Tuberc Respir Dis(Seoul),2013,75(6):260-263.
  • 6Wauters J,Baar I,Meersseman P,et al.Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1patients:a retrospective study[J].Intensive Care Med,2012,38(11):1761-1768.
  • 7Mittal A,Gahlaut A,Sharma GL,et al.Antifungal Treatments Delineate a Correlation between Cathepsins and Cytokines in Murine Model of Invasive Aspergillosis[J].Indian J Pharm Sci,2013,75(6):688-699.
  • 8Eerd JE,Rennen HJ,Oyen WJ,et al.Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene 134 antagonist.J Nucl Med. 2004;45(10): 1747-1753.
  • 9Habicht JM,Preiss M,Passweg J,et,al.lnvasive pulmonary aspergillosis:effects of early resection in a neutropenic rat model. Eur J Cardiothorac Surg. 2002;22(5):728-732.
  • 10Sheppard DC,Rieg G, Chiang LY, et al.Novel inhalational mralrte Mdoel of invasive pulmonary aspergillosis.Antlmicrob Agent Chemother. 2004;48(5): 1908-1911.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部